Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Free Drug Samples: Use and Abuse

Free Drug Samples: Use and Abuse This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables. Abstract On May 14, 1986, Congressman John Dingell, chairman of the US House Energy and Commerce Committee, along with ten cosponsors, introduced a bill, HR 4820, designed "to amend the Federal Food, Drug, and Cosmetic Act to ban the reimportation of drugs produced in the United States, to place restrictions on drug samples, to ban certain resales of drugs purchased by hospitals and other health care facilities, and for other purposes." Section 5 of this legislation would prohibit direct distribution of free samples of drugs to physicians by representatives or other employees of drug manufacturers. The manufacturer would be allowed to mail samples to physicians on written request, and the physician must return a receipt to the manufacturer. All records of such transactions must be retained by the manufacturer. On Sept 24, 1986, Senator Spark Matsunaga, with nine cosponsors, introduced identical legislation (S 2875) into the US Senate. These bills have http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Archives of Dermatology American Medical Association

Free Drug Samples: Use and Abuse

Archives of Dermatology , Volume 124 (1) – Jan 1, 1988

Loading next page...
 
/lp/american-medical-association/free-drug-samples-use-and-abuse-IEfMXRqXGm
Publisher
American Medical Association
Copyright
Copyright © 1988 American Medical Association. All Rights Reserved.
ISSN
0003-987X
eISSN
1538-3652
DOI
10.1001/archderm.1988.01670010091030
Publisher site
See Article on Publisher Site

Abstract

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables. Abstract On May 14, 1986, Congressman John Dingell, chairman of the US House Energy and Commerce Committee, along with ten cosponsors, introduced a bill, HR 4820, designed "to amend the Federal Food, Drug, and Cosmetic Act to ban the reimportation of drugs produced in the United States, to place restrictions on drug samples, to ban certain resales of drugs purchased by hospitals and other health care facilities, and for other purposes." Section 5 of this legislation would prohibit direct distribution of free samples of drugs to physicians by representatives or other employees of drug manufacturers. The manufacturer would be allowed to mail samples to physicians on written request, and the physician must return a receipt to the manufacturer. All records of such transactions must be retained by the manufacturer. On Sept 24, 1986, Senator Spark Matsunaga, with nine cosponsors, introduced identical legislation (S 2875) into the US Senate. These bills have

Journal

Archives of DermatologyAmerican Medical Association

Published: Jan 1, 1988

There are no references for this article.